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The results of this study demonstrate that murine cytomegalovirus (MCMV) induces polyclonal B cell activation in mice
during the acute phase of primary infection. First, flow cytometric analysis revealed that surface expression of CD45R, IgM,
and Igk by splenocytes from MCMV-infected mice was significantly reduced with a concomitant increase in the frequency
of surface IgG-expressing cells. Second, ELIspot assays demonstrated that the changes revealed by flow cytometry were
paralleled by increases in the numbers of IgG-producing cells, especially those secreting IgG2a. Third, the IgG antibodies
from MCMV-infected animals reacted against a variety of self and foreign antigens. MCMV-induced B cell activation was
independent of CD41 T-cell-mediated help and CD40, since activation was observed in two models of mice deficient for this
T cell subset and in mice deficient for CD40. Reverse transcription–polymerase chain reaction analysis showed that mRNA
transcripts for the cytokines IL-6, IL-10, and IFN-g were rapidly induced following infection with MCMV, but only IL-6 and
IFN-g proteins were detectable by ELISA. In addition, the numbers of cells producing IL-6 and IFN-g were significantly
increased in the spleen. The magnitude of the polyclonal B cell activation response was diminished by 50% in IL-6-deficient
mice but not in mice lacking IFN-g. In the absence of IFN-g, surface expression and serum levels of IgG2a were reduced while
IgG1 expression was increased. © 1998 Academic Press
INTRODUCTION
The high incidence of human cytomegalovirus infec-
tion in the general population is seldom a major medical
problem, but in immunocompromised patients, it is a
leading cause of mortality (Neiman et al., 1973; Moskow-
itz et al., 1985; Ho, 1991a). Because of several similarities
in its biology and disease spectrum, murine CMV
(MCMV) has been a useful model in understanding the
pathogenesis of CMV infections in humans (Hudson,
1979). Like other herpesvirus infections, acute CMV in-
fection is followed by chronic infection and viral latency
(Bruggeman, 1993). Reactivation of latent virus can occur
under conditions of immunosuppression and immunode-
ficiency (Fiala et al., 1991; Ho, 1991b; Bruggeman, 1993).
Establishment of latency in the infected host by MCMV
and other herpes viruses is poorly understood but may
be due to the ability to avoid elimination in the acute
phase of the disease (Banks and Rouse, 1992). Early in
the course of an acute MCMV infection, NK cells are
believed to control virus replication prior to the induction
of antiviral T cell and antibody responses. During the NK
and T cell responsive phases of the infection, spleen
cells from MCMV-infected mice are hyporesponsive to T
and B cell mitogens, alloantigens, and viral antigens
(Selgrade et al., 1976; Kelsey et al., 1978; Ho, 1980; Loh
and Hudson, 1981; Nicholas et al., 1987; Campbell et al.,
1989). Despite this suppression of the T cell compart-
ment, an effective antiviral T cell response is neverthe-
less generated that can control the infection; however, it
can prevent neither virus persistence nor the establish-
ment of latency (Koszinowski et al., 1990).
Although passively transferred virus-specific antibod-
ies are protective (Shanley et al., 1981; Farrell and Shel-
lam, 1991), antibodies are not essential for recovery from
a primary MCMV infection (Jonjic et al., 1994). Antibodies
are important, however, in limiting reactivation and dis-
semination of latent virus (Jonjic et al., 1994). Infection
with HCMV is frequently associated with a number of
transient humoral abnormalities—mixed cryoglobulins,
cold agglutinins, rheumatoid factor, antinuclear antibod-
ies, and anticomplementary activity (Klemola et al.,
1970)—that may be attributable to virus-induced poly-
clonal B cell activation (Hutt-Fletcher et al., 1983). The
appearance of autoantibodies in serum of mice infected
with MCMV may also be caused by widespread activa-
tion of B cells (Price et al., 1993).
Our preliminary studies of mice injected with MCMV
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strengthened this suggestion in revealing that the tran-
sient splenomegaly observed in mice infected as adults
was associated with a major expansion of activated B
cells and isotype switching from IgM to IgG expression.
The experiments described here were designed, first, to
determine whether these B cell responses were poly-
clonal and if they were dependent on the presence of
CD41 T cells. Ig synthesis and class switching by B cells
responding to T-dependent antigens require cognate
T–B interactions through CD40/CD40 ligand (CD40L)
binding and cytokines produced primarily by CD41 T
cells. Some cytokines affecting B cell physiology can be
produced by non-T cells, however, and viral infections
are often potent inducers of cytokine expression (Bowen
et al., 1992). Further experiments were undertaken to
examine the pattern of cytokine expression associated
with B cell activation during the course of MCMV infec-
tion. The contribution of some of these cytokines and the
requirement for CD40 in the B cell activation process
were also investigated.
MATERIALS AND METHODS
Mice
Female, specific-pathogen-free (SPF), euthymic C3B-
7/ByJ (C3BK) (H-2b), C57BL/6J (B6) (H-2b), BALB/cJ
(BALB/c) (H-2d), and B10.BR (H-2k) mice and B6 and
BALB/c mice bearing the nude mutation (nu) (B6-nu/nu;
BALB/c-nu/nu) were obtained from the Jackson Labora-
tories (Bar Harbor, ME) and used at 6 to 16 weeks of age.
Mice deficient in MHC class II expression resulting from
germline disruption of the Ab
b gene (C2D2/2) (Grusby et
al., 1991) were fifth generation backcross to B6 mice and
were purchased from GenPharm International (Mountain
View, CA) along with controls expressing MHC class II
(C2D1/1). C2D2/2 mice lack CD41 T cells and have
increased frequencies of CD81 T cells (Bowen et al.,
1992). Mice deficient in CD40 (Kawabe et al., 1994) and
IL-6 (Kopf et al., 1994), both of B6 3 129 background, and
mice deficient in IFN-g (Dalton et al., 1993) on a B6
background were bred under SPF conditions at the An-
imal Breeding Establishment, John Curtin School of Med-
ical Research.
Virus
The Smith strain of MCMV was salivary gland-pas-
saged and a 10% homogenate prepared in Dulbecco’s
MEM (DMEM) containing 20% veal infusion broth. Mice
were inoculated ip with a dose of virus adjusted appro-
priately for each strain to provide resistance to lethal
challenge; this was approximately 10-fold lower than the
LD50. The doses given to individual mouse strains are
given in Table 1.
Cell lines
The murine fibroblast NIH-3T3 cells were maintained
in DMEM containing 10% heat-inactivated bovine serum
(BS), L-glutamine, and antibiotics.
Flow cytometry
The following fluorochrome-conjugated mAbs to mu-
rine cell surface antigens were used for single color
analysis: FITC-conjugated anti-IgG1 (clone G1-6.5), anti-
IgG2a (clone R19-15), anti-IgG2b (clone R12-3), anti-IgG3
(clone R40-82), anti-CD45R (B220; clone 6B2), anti-IgA
(clone RMA-02), and biotinylated anti-NK1.1 (clone PK
136) were obtained from PharMingen (San Diego, CA).
Anti-IgM (clone LO-MM-9; Zymed Laboratories, South
San Francisco, CA), anti-Ig k-chain (clone MCA152F;
Serotec Ltd., Oxford, England), and goat anti-mouse IgG
(Southern Biotechnology Associates, Birmingham, AL)
were also used as FITC-conjugated antibody. Avidin–
allophycocyanin was obtained from Molecular Probes
(Eugene, OR). Spleen cells were prepared and stained as
described previously (Karupiah et al., 1993). For each
sample, 20,000 events were collected and analyzed on a
FACS 440 flow cytometer (Becton Dickinson Immunocy-
tometry Systems, San Jose, CA) at the NIH and on a
FACscan flow cytometer (Becton Dickinson Immunocy-
tometry Systems) at the JCSMR.
CD41 T cell depletion in vivo
Acute depletion of the CD41 T cell subset in vivo was
achieved using a mAb to the CD4 antigen (clone GK1.5,
rat IgG2b). The mAb was partially purified using saturated
ammonium sulfate and the concentration was deter-
mined by radial immunodiffusion (The Binding Site Inc.,
San Diego, CA). Mice were treated with the mAb ip at 1
mg/day/mouse twice before infection (days -3 and -1), 1
day after infection (day 1), and every 4 days thereafter
TABLE 1
Mouse Strains and Virus Doses
Mouse strain
LD50
(PFU)
Dose used
(PFU) Gene knockout mice
C3BK 105.9 104.9 —
C57BL/6 106.9 105.9 IFN-g2/2
BALB/c 105.9 104.9 —
B10.BR .107.5 106.9 —
B6-nu/nu NDa 103.9 —
BALB/c-nu/nu ND 103.4 —
B6 3 129b 107.5 105.9 CD402/2IL-62/2
C2D 107.5 106.5 MHC class II2/2
a ND, not determined.
b A lower virus dose was used for this particular strain because the
IL-62/2 and CD402/2 mice, both on a B6 3 129 background, were more
susceptible than wild-type B6 3 129 mice to lethal infection with
MCMV.
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until termination of the experiment. Efficiency of deple-
tion was assessed by flow cytometric analysis of spleen
cells; all treated mice had less than 1% CD41 T cells.
Anticytokine mAb treatment
Immunomodulation studies using neutralizing mAbs to
cytokines were undertaken to determine whether IFN-g,
TNF-a, or IL-10 contributed to the activation of B cells in
this model. MCMV-infected mice were treated with par-
tially purified ascites containing mAbs to IFN-g (clone
XMG-6; 3 3 1 mg/mouse/week), TNF-a (clone XT-22/11;
3 3 0.5 mg/mouse/week), or IL-10 (clones SXC-1 and
SXC-2; 4 3 2 mg/mouse/week). The effect of mAb treat-
ment on MCMV-induced B cell activation was assessed
by flow cytometry.
Isolation and purification of mRNA from spleens
Individual spleen samples were homogenized in 1 ml
RNAzol (Cinna Biotecx, Friendswood, TX), and total RNA
was isolated according to the manufacturer’s instruc-
tions. The RNA was resuspended in 200 ml diethylpyro-
carbonate-treated water containing 1 mM EDTA and
quantitated spectrophotometrically.
Reverse transcription–polymerase chain reaction
(RT-PCR) for cytokine mRNA detection
The relative quantities of mRNA for the cytokines IL-2,
IL-4, IL-5, IL-6, IL-10, IL-12 (p35 and p40 chains), IL-13,
IFN-g, TNF-a, and the housekeeping gene HPRT were
determined using a RT-PCR procedure as described
elsewhere (Svetic et al., 1991; Wynn et al., 1993). The
sense and antisense primers and probes for all cyto-
kines and HPRT have been described previously (Svetic
et al., 1991; Wynn et al., 1993). The probes were designed
to hybridize to a portion of the amplified segment be-
tween the primers, which ensured the identity of the
segment amplified.
The PCR reaction conditions had been predetermined
and defined for each cytokine primer pair such that a
linear relationship between input RNA and final PCR
product was obtained (Wynn et al., 1993). Known positive
and negative controls were included in each assay to
confirm that only cDNA PCR products were detected and
that none of the reagents was contaminated with cDNA
or any previous PCR products. After amplification, the
DNA was analyzed by electrophoresis, Southern blotting,
and hybridization with nonradioactive cytokine-specific
probes as described previously (Wynn et al., 1993). For
each cytokine, results were normalized for the relative
quantity of total mRNA by comparison to HPRT. Values
are expressed as fold increase/decrease of mRNA ex-
pression in the spleen over that of control, uninfected
mice (day 0), which are assigned an arbitrary value of 1
and represent the mean and standard deviation of cyto-
kine mRNA levels in the spleens of three individual
mice/group.
Cell preparation for ELIspot assays
Animals were killed by cervical dislocation. Single-cell
suspensions were prepared from the spleen, bone mar-
row, mesenteric lymph nodes, and peritoneal exudate
and washed three times in RPMI supplemented with 5%
FCS. Cells were counted and adjusted to a concentration
appropriate for each experiment.
ELIspot for antibody isotype and antigen specificity
Flat-bottom Immulon I microtiter plates (PGC Scientif-
ics, Gaithersburg, MD) were coated with goat anti-
mouse IgG (Southern Biotechnology Associates) for 2 h
and blocked with 1% BSA in PBS for 2 h. For antibody
specificity, flat-bottom plates were coated with ovalbu-
min, actin, TNP, ssDNA, myoglobin, or HIV-1 gp 120
(Monestier et al., 1986; Klinman and Steinberg, 1987) and
blocked as described. After blocking, plates were
washed three times with PBS containing 0.025% Tween
and rinsed three times with distilled H2O. Serial dilutions
were performed from an initial cell number of 106/well.
Cells were incubated in 150 ml of RPMI 1640 with 5% FCS
for 6–7 h at 37°C in a CO2 incubator, after which plates
were washed as described (Klinman and Steinberg,
1987) and then incubated overnight with a 1:1000 dilution
of alkaline phosphatase-labeled anti-IgG, IgG1, IgG2a,
IgG2b, IgG3, or IgM (Southern Biotechnology) in PBS–
BSA. Washed plates were developed with an agar solu-
tion containing 5-bromo-3-chloroindoyl phosphate solu-
tion (Sigma Chemical Company). The number of spots/
well was used to determine the number of cells/106
secreting Ig in vivo. The total number of cells producing
Ig per organ was then calculated and used to determine
the total number of cells secreting per animal (i.e.,
spleen 1 bone marrow 1 lymph nodes 1 peritoneal
exudate). Ratios of secreting cells were calculated using
the total number of secreting cells.
Cytokine ELIspot
Millititer HA 96-well filtration plates (Millipore Corp.,
Bedford, MA) were coated overnight with anti-IL-2 (clone
JES6-1A12 diluted 1:50; PharMingen), anti-IL-4 (clone
BVD6-24G2 diluted 1:75; Endogen, Boston, MA), anti-IL-6
(clone MP5-2053 diluted 1:75; PharMingen), or anti-IFN-g
(clone R4-6A2 diluted 1:100; Lee Biomolecular, San
Diego, CA) in 0.1 M carbonate buffer. Plates were
blocked with 5% BSA 1 0.025% Tween 1 PBS for 2 h and
washed as described. Cells were serially diluted in me-
dium supplemented with 5% FCS as described and in-
cubated in a total volume of 100–150 ml for 5–6 h. Fol-
lowing incubation, plates were washed with H2O 1
0.025% Tween with a Titertek plate washer (ICN-Flow,
Costa Mesa, CA). Anti-IL-2 (clone JES6-5H4 diluted 1:500;
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PharMingen), anti-IL-4 (clone IIBII diluted 1:4000), anti-
IL-6 (clone MP5-32C11 diluted 1:1000; PharMingen), or
anti-IFN-g (clone XMG1.2 diluted 1:1000; PharMingen) in
PBS 1 0.025% Tween 1 BSA was added to the corre-
sponding plates and refrigerated overnight. After incuba-
tion for 1 h at room temperature, a 1:2000 dilution of
avidin (Vector Laboratories, Burlingame, CA) was added
to the washed plates. Plates were then incubated 1 h at
room temperature, washed, and developed with BCIP-
NBT (Kirkegaard and Perry, Gaithersburg, MD) for 30 min.
After developing, plates were rinsed with distilled H2O
and allowed to dry. Spots were counted the following day
with a dissecting microscope. Cell numbers were calcu-
lated and analyzed as described above.
Detection of antibodies by ELISA
Flat-bottom microtiter plates were coated with ovalbu-
min, TNP, and myoglobin and blocked as described (Klin-
man and Steinberg, 1986, 1987). Sera (diluted to 1:50 in
PBS–Tween followed by serial twofold dilutions) from
uninfected control and MCMV-infected mice were added
to wells, and the presence of antibodies reactive with
ovalbumin, TNP, and myosin was detected using, in or-
der, biotinylated goat anti-mouse IgM or IgG followed by
streptavidin-conjugated alkaline phosphatase and phos-
phatase substrate. Total IgM and IgG concentrations
were determined using appropriate primary goat anti-
mouse antibody for capture and biotinylated goat anti-
mouse for detection (Southern Biotechnology).
Responses to concanavalin A (Con A) and LPS
Splenocytes (1 3 107) from groups of three uninfected
and MCMV-infected mice were cultured in wells of 24-
cluster plates in RPMI containing 10% FCS, 500 mM
2-ME, L-glutamine, sodium pyruvate, and nonessential
amino acids (complete RPMI). The T cell mitogen Con A
(4 mg/ml) and B cell mitogen bacterial lipopolysaccharide
(LPS; 10 mg/ml) were added to some cultures, whereas
others were left untreated. After 72 h, cultures were
harvested and spun at 2000 rpm in a bench-top centri-
fuge maintained at 4°C for 5 min, the cell-free superna-
tants were collected, and the presence of cytokines was
determined by ELISA.
ELISAs for cytokines
Standard sandwich ELISAs were performed for detec-
tion of IL-2, IL-4, IL-10, and IFN-g in culture supernatants
using appropriate primary mAb for capture and biotiny-
lated mAb for detection. Antibody pairs and cytokine
standards were obtained from PharMingen. When nec-
essary, supernatants were diluted in complete RPMI
before cytokine levels were quantitated. IL-6 in culture
supernatants was quantitated using an ELISA kit (Endo-
gen) according to the manufacturer’s instructions.
Histopathology
Mice were necropsied, and spleen, liver, lung, salivary
glands, and cervical lymph nodes were fixed in 10%
buffered formalin and embedded in paraffin. Sections (5
mm) were stained with hematoxylin and eosin.
RESULTS
CD41 T-cell-independent B cell activation following
MCMV infection
Spleen cells from uninfected and MCMV-infected
CXBK mice were stained with fluorochrome-conju-
gated mAbs. Alterations in splenocyte populations
were assessed by flow cytometric analysis (Fig. 1).
The most obvious changes noted for B cells of infected
mice were severely reduced levels of CD45R (B220)
and surface IgM and Igk expression with concomitant
increases in surface IgG expression (Fig. 1A) and cell
size (data not shown), consistent with B cell activation.
There was also a dramatic increase in the expression
of the NK cell marker NK1.1 (Fig. 1). Changes in T cells
were more modest. The frequency of CD41 cells was
reduced from 17% in normal spleens to 12% in spleens
of mice infected for 10 days, while the frequencies of
CD81 T cells were 7 and 6%, respectively, for these
animals. These changes correlated with increases in
spleen weight and cellularity and were apparent as
early as 5 days after infection (data not shown). Max-
imal changes were detected at 10 days (Fig. 1A), but
levels had returned to normal by 14 days after infection
(data not shown). Very similar changes were observed
following infection of another MCMV-susceptible
mouse strain (BALB/c) and two genetically resistant
mouse strains (B10.BR and B6), the latter strains re-
quiring infection with higher doses of virus (see Ma-
terials and Methods). In both resistant and sensitive
strains, B cell activation, assessed by flow cytometry,
was evident provided the mice were productively in-
fected with an appropriate dose of virus.
We next determined whether this phenomenon of B
cell activation was dependent on CD41 T cells. Flow
cytometric analysis of splenocytes from MCMV-infected
CXBK mice depleted of CD41 T cells by treatment with
mAb GK1.5 established that B cell activation in these
circumstances did not require the presence of this sub-
set of T cells. Although the effects of infection were
slightly diminished compared with those seen in control
MCMV-infected mice (Fig. 1A), B cells from CD41 T-cell-
deficient mice clearly had reduced levels of CD45R
(B220), IgM, and Igk, concomitant with an increase in the
frequency of surface IgG-expressing cells, consistent
with activation (Fig. 1B). Similar observations were made
in mice lacking CD41 cells because of disruption of the
Ab
b gene (C2D2/2) and in two strains (B6, BALB/c) of
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FIG. 1. Flow cytometric analysis of splenocytes for expression of B cell markers and NK1.1 antigen. Spleens were obtained from control, uninfected
(solid lines), or 10-day MCMV-infected (dashed lines) CXBK mice. (A) Expression of CD45R, IgM, Igk, IgG, and NK1.1 antigens on splenocytes of CXBK
mice with intact CD41 T cells. (B) Expression of the same markers on splenocytes of mice depleted of CD41 T cells. Data shown are representative
of two separate experiments with five mice in each group.
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athymic (nu/nu) mice that lack functional T cells (data not
shown).
Further analysis using IgG subclass-specific mAb con-
jugates indicated pronounced increases in surface ex-
pression of IgG2a and IgG2b and marginal increases in
surface IgG1 and IgG3 expression on spleen cells from
MCMV-infected CXBK mice (Fig. 2A). These changes
were also evident in CD41 T-cell-depleted CXBK mice
(Fig. 2B) and in the CD41 T-cell-deficient C2D2/2 mice
(data not shown).
Enumeration of antibody-producing cells by ELIspot
assay
In order to establish whether the increased levels of
surface IgG expression on B cells were paralleled by
increases in the number of antibody-producing cells, we
used an ELIspot assay to enumerate isotype-specific
and IgG subclass-specific antibody-producing cells us-
ing lymphocytes obtained from the spleen, bone marrow,
lymph node, and peritoneum of mice at various intervals
FIG. 2. Analysis by flow cytometry for surface expression of IgG subclasses using the same spleen cell samples described in Fig. 1. IgG subclass
expression on splenocytes from control, uninfected (solid lines), or MCMV-infected (dashed lines) CXBK mice with intact CD41 T cells (A) and in mice
depleted of CD41 T cells (B). Results shown are representative of two separate experiments with four mice in each group.
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following infection. No increase in the number of IgM-
producing cells was apparent during the first 15 days
after infection, although a 10-fold increase was noted in
a single experiment at day 24 (Fig. 3). In contrast, the
total number of IgG-secreting cells was increased at 5
days after infection, peaked at day 10, and decreased
thereafter. At day 24, the numbers were still higher than
those for uninfected mice. Analyses of individual IgG
subclasses indicated that maximal changes occurred at
day 10 postinfection, consistent with flow cytometric
analyses. At that time, the most pronounced increases
were seen in the number of IgG2a-producing cells (2000-
fold), followed by IgG1 (100-fold), IgG3 (50-fold), and IgG2b
(10-fold) (Fig. 3).
Antibody specificity of ig-secreting cells
The reactivity of the antibody in sera from MCMV-
infected mice with tissues from uninfected syngeneic
mice (Bartholomaeus et al., 1988) is believed to be as-
sociated with the production of autoantibodies as a con-
sequence of infection. We therefore investigated whether
B cell activation induced by MCMV was polyclonal in
nature and if this phenomenon was responsible for au-
toantibody production by testing the antibody specificity
of Ig-producing cells. At 10 days after infection, the num-
ber of IgM-producing cells was relatively unchanged,
and the antibody they produced had minimal reactivity
with any of a series of autoantigens (DNA, myosin, and
actin), conventional antigens (ovalbumin and TNP), or the
unrelated viral antigen (HIV-1 gp 120) (Figs. 3 and 4). In
contrast, the number of IgG-producing cells was in-
creased by about 130-fold (Fig. 4; see also Fig. 3), and the
IgG produced by B cells from virus-infected mice dis-
played a broad range of reactivities with the antigens
tested. The number of B cells secreting IgG antibodies
against TNP was increased 175-fold; against ssDNA,
180-fold; against myosin, 95-fold; against ovalbumin, 110-
fold; against actin, 70-fold; and against HIV gp 120, about
40-fold over the numbers of cells with these specificities
from uninfected mice (Fig. 4). Thus, the B cell activation
induced by MCMV infection was truly polyclonal and
resulted in the production of IgG antibodies against a
broad spectrum of conventional, self, and unrelated viral
antigens.
Antibody specificity of sera from CD40-deficient mice
MCMV-induced B cell activation was not dependent
on the presence of CD41 T cells (Figs. 1B and 2B). This
suggested the possibility that the production of antibod-
ies reactive with self, conventional, and unrelated viral
antigens may not require signaling via CD40–CD40L. To
test this possibility, the reactivity of sera from MCMV-
infected CD40-deficient mice with ovalbumin, myosin,
and TNP was examined. Ten days after infection, IgG
FIG. 4. Antibody specificity of C3BK Ig-secreting cells. The fold
increases in the numbers of IgM (h)- and IgG (n)-producing cells with
reactivity to unrelated antigens was determined as described. Antibod-
ies of the IgG isotype displayed reactivity with a panel of autoantigens
(ssDNA, actin, and myosin), conventional antigens (TNP and ovalbu-
min), and HIV-1 gp 120. Data shown are representative of two separate
experiments with three mice/group for each time point.
FIG. 3. Enumeration of antibody producing cells by ELIspot assay of
C3BK spleen cells. The total number of lymphoid cells producing
isotype-specific and subclass-specific antibody were obtained by add-
ing individual numbers measured in the spleen, bone marrow, mesen-
teric lymph node, and peritoneum. Numbers shown are the average 1
1 SD for three mice/group for each time point. (A) IgM (F) and IgG (n)
and (B) IgG subclasses: IgG1 (E), IgG2a (h), IgG2b (), and IgG3 ().
Data shown are representative of two separate experiments with three
mice/group for each time point.
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isotype antibodies reactive with all three antigens were
increased between 20- and 30-fold compared with anti-
body levels in sera from uninfected CD40-deficient mice
(Fig. 5). The increases were between 2- and 3-fold higher
than increases seen in similarly infected wild-type mice.
The extremely low levels of circulating IgG in sera of
uninfected mutant mice most likely contributed to the
massive increase in the levels of total IgG as well as IgG
crossreactive with self and conventional antigens.
MCMV-induced polyclonal B cell activation was thus
independent of CD40/CD40L interaction.
Analysis of cytokine mRNA expression by RT-PCR
Although the polyclonal B cell activation in MCMV-
infected mice was independent of CD41 T-cell-mediated
help, the process could nevertheless be driven by cyto-
kines produced by cell populations other than this T cell
subset. We therefore analyzed the induction of mRNA
transcripts for a number of cytokines in the spleen using
RT-PCR. By this procedure, it was found that the levels of
mRNA for IL-2 and the p40 chain of IL-12 did not change
significantly compared with uninfected controls during
the first 10 days of infection but were below the levels
expressed by uninfected animals at day 14 (Fig. 6a). The
mRNA transcripts for TNF-a were increased only by 1.2-
to 2-fold over the entire course of infection analyzed. The
most striking changes in the levels of mRNA transcripts,
however, were observed for IL-4, IL-6, IL-10, and IFN-g,
cytokines known to influence B cell proliferation, activa-
tion, and Ig synthesis. Among these, only IL-4 mRNA
expression was severely depressed during the first few
days after infection, and especially at day 5 (down by
500,000-fold) (Fig. 6b). At days 10 and 14, however, the
levels of IL-4 increased by 9- and 4-fold, respectively,
over basal levels. In contrast to IL-4, levels of IL-6 and
IL-10 mRNA expression were increased by several or-
ders of magnitude at 3 day p.i. and remained high
through day 10 for IL-6 and day 7 for IL-10, returning to
background levels thereafter (Figs. 6a and 6b). IFN-g
mRNA transcripts were also increased over the course of
infection with kinetics similar to IL-6, although the fold
increases were not as dramatic. No changes above the
very low background levels in mRNA transcripts were
noted for IL-5 and IL-13, two other cytokines that could
potentially affect B cell antibody responses (data not
shown).
Quantitation of cytokines by ELISA and ELIspot assay
Measurements of cytokine expression at the protein
level were performed to determine whether increases in
the mRNA transcripts were paralleled by increased pro-
tein products. First, supernatants from mitogen-stimu-
lated and unstimulated splenocyte cultures were used to
measure cytokine levels by ELISA. Second, splenocytes
obtained from uninfected and virus-infected mice were
used ex vivo in an ELIspot assay to determine whether
the changes in cytokine mRNA expression levels were
related to increases in numbers of cytokine-producing
cells following infection with MCMV.
IL-2 was not detected by ELISA in unstimulated (spon-
taneous production) or LPS-stimulated cultures of spleen
cells from uninfected or MCMV-infected mice. Stimula-
tion with Con A resulted in IL-2 production in splenocyte
cultures established from uninfected mice or from mice
infected for 3 days (Fig. 7A), but this response was
lacking in cultures of spleen cells obtained from mice 5
and 7 days after infection. In the case of IFN-g, no
spontaneous production was noted even after infection,
but large amounts of this cytokine were detected in
cultures treated with Con A or LPS. IFN-g production in
FIG. 5. Antibody specificity of sera from CD40-deficient B6 3 129 mice. The fold increases in levels of serum Ig in MCMV-infected CD401/1 (A)
and CD402/2 (B) mice reactive with ovalbumin, myosin, and TNP above levels in uninfected control B6 3 129 mice were determined. Results are
representative of two separate experiments with five mice/group.
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FIG. 6. (a) Kinetics of cytokine mRNA expression in MCMV-infected C3BK mice. mRNA isolated from spleens of uninfected (day 0) or
MCMV-infected (days 3, 5, 7, 10, and 14) mice was reverse transcribed, the cDNA was amplified using appropriate cytokine primer pairs, and products
were detected after electrophoresis. Southern blotting and hybridization with relevant probes were as described. The resultant bands show areas of
specific probe hybridization. For each day, mRNA samples from spleens from three animals were used. (b) Fold increase/decrease of cytokine mRNA
expression in spleens of MCMV-infected mice over control, uninfected mice. The band intensities were quantitated by densitometry. Values are
expressed relative to uninfected controls (day 0), which are assigned an arbitrary value of 1. Data represent the mean and the SD from the spleens
of three individual mice. Results are representative of two separate experiments with three mice/group for each time point.
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response to LPS peaked between days 3 and 5 postin-
fection, whereas the Con A response peaked at day 7
(Fig. 7b). This may be a reflection of different cell popu-
lations producing this cytokine at different times after
infection. In contrast to IL-2 and IFN-g, spontaneous IL-6
production was detected in splenocyte cultures from
uninfected mice, and this increased by more than 10-fold
at day 3 p.i., over 13-fold at day 5, and remained in-
creased, about 9-fold over endogenous levels, at day
7 p.i. Stimulation with Con A and LPS enhanced IL-6
production by several orders of magnitude (Fig. 7C).
Under conditions of stimulation with Con A or LPS or no
stimulation, neither IL-4 nor IL-10 was detected in cul-
tures by ELISA.
The total numbers of cells producing IL-2, IL-4, IL-6,
and IFN-g were enumerated by the ELIspot assay (Fig.
8). While the number of IL-2 producing cells actually
decreased over the course of infection, the numbers of
IL-6 and IFN-g-producing cells were clearly increased,
consistent with changes that correlated with maximal
production of these cytokines detected by ELISA (Fig. 8).
Although IL-4-producing-cells were detected by the ELIs-
pot assay, the numbers did not change during the course
of infection. Failure to detect IL-4 by ELISA may be due to
an inability of the assay to detect very low levels of the
cytokine. The reason for the unusually low numbers of
IL-2-producing cells at day 5 is not clear, but it was a
reproducible finding.
Response of mice deficient in IL-6 or IFN-g to MCMV
The two proinflammatory cytokines IL-6 and IFN-g
profoundly influence B cell physiology and can be pro-
duced by non-T cells. Both cytokines, and in particular
IL-6, were produced in large amounts by splenocytes
from MCMV-infected mice. In order to determine whether
either of these cytokines contributed to virus-induced
polyclonal B cell activation, mice deficient in IL-6 or
IFN-g and appropriate controls were inoculated with
MCMV. Flow cytometric analysis of splenocytes 10 days
after infection confirmed that the B cell activation re-
sponses in IFN-g2/2 and IFN-g1/1 mice were similar
except that the proportion of IgG2a-expressing cells was
decreased in the mutant mice by twofold, and a concom-
itant increase in IgG1 expression was noted (data not
shown). In contrast, similar analysis of splenocytes from
FIG. 8. Enumeration of cytokine-producing cells by ELIspot assays of
C3BK mice. Data shown are from one of two experiments with similar
outcomes using three mice for each time point. The numbers of cells
producing IL-2 (F), IFN-g (), IL-4 (n), and IL-6 () were determined in
the spleens of uninfected (day 0) and MCMV-infected (days 5, 10, 15,
and 24) mice.
FIG. 7. Quantitation of cytokines (protein) by ELISA. The presence of
(A) IL-2, (B) IFN-g, and (C) IL-6 in unstimulated, Con A-stimulated, or
LPS-stimulated splenocyte cultures of C3BK mice was determined.
Data shown are representative of two separate experiments using
splenocytes from individual mice in triplicate cultures for each restimu-
lation condition.
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IL-62/2 mice indicated that B cell activation was not as
profound as that seen in the control IL-61/1 mice (data
not shown). While the levels of CD45R, surface IgM, and
Igk expression in MCMV-infected IL-61/1 mice were
reduced dramatically (comparable to Fig. 1), those in
IL-62/2 mice were not (data not shown).
The reactivity of serum IgG from MCMV-infected IL-
61/1 mice with ovalbumin, myosin, and TNP was in-
creased by 5- to 10-fold over that of uninfected IL-61/1
mice (Fig. 9); however, sera from virus-infected IL-62/2
mice had lower levels of ovalbumin-, myosin-, and TNP-
specific IgG. Compared with MCMV-infected IL-61/1
mice, the fold increases of the crossreactive antibodies
in mutant mice were about 50% less, and fold increases
in total IgG were 1.5-fold lower. The levels of ovalbumin-,
myosin-, and TNP-crossreactive IgG and IgM antibodies
in uninfected mutant and wild-type mice were similar.
Deficiency in IFN-g did not affect the capacity of B
cells from MCMV-infected mice to produce IgG antibod-
ies reactive with ovalbumin, myosin, and TNP (Fig. 9).
The only obvious difference was that in IFN-g2/2 mice,
serum IgG2a levels were reduced by threefold with a
concomitant twofold increase in IgG, levels compared
with IFN-g1/1 mice (data not shown).
Histopathology
Studies of tissues obtained at autopsy of infected mice
showed striking germinal center expansion in spleens
and lymph nodes that was maximal by day 10 after
infection (Fig. 10) but had resolved almost entirely by day
21. In contrast, tissues of infected mice deficient in CD41
T cells as a result of treatment with anti-CD4 mAb,
absent MHC class II expression or the nude defect, were
strikingly different in being devoid of germinal centers.
The absence of germinal centers in CD4-deficient mice
can most likely be explained by the absence of T cells
expressing CD40L, which is required for germinal center
FIG. 9. Antibody specificity of sera from IL-6-deficient and IFN-g-deficient mice 10 days after infection with MCMV. The fold increases over normal
in levels of serum Ig in IL-61/1 (A), IL-62/2 mice (B6 3 129 background) (B), IFN-g1/1 (C), and IFN-g2/2 (D) mice (B6 background) reactive with
ovalbumin, myosin, and TNP were determined. Data shown are representative of two separate experiments using five mice for each group. ELISAs
were carried out in triplicate for individual serum samples against each antigen tested. The SEM were less than 5% and have been omitted for clarity.
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formation (Durie et al., 1994; Kawabe et al., 1994). Flow
cytometric analyses revealed comparable B cell changes
in spleens of infected mice with and without CD41 T
cells either having or lacking germinal centers, respec-
tively.
DISCUSSION
Data presented here establish that MCMV induces
polyclonal B cell activation during the acute phase of
primary infection. The antibodies produced had broad
crossreactivity with a panel of autoantigens, conven-
tional antigens, and the unrelated HIV-1 gp 120. These
results are consistent with previous studies of the MCMV
model (Price et al., 1993) and may be pertinent to the
occurrence of autoreactive antibodies in humans follow-
ing infection with HCMV (Hutt-Fletcher et al., 1983). The
culturing of live or UV-inactivated HCMV with human
peripheral blood B cells has been shown to induce
polyclonal B cell activation and Ig synthesis, suggesting
that some component(s) of the virus can either directly or
indirectly activate B cells and that this process is inde-
pendent of CD41 T cells. In the current studies, infection
with MCMV-induced B cell activation in two different
models of CD41 T-cell-deficient mice and in nu/nu mice,
which lack functional CD41 and CD81 T cells. This
finding differs from a previous study (Price et al., 1993) in
which the activation of B cells following infection with
MCMV was found to be dependent on CD41 T cells. The
differences with respect to the requirement for helper
functions of CD41 T cells in our study and the previous
report are not clear. They cannot be attributed to differ-
ences in virus, as both studies used the Smith strain of
MCMV passaged in salivary gland and both studies
examined mice depleted of CD41 T cells with GK1.5
mAb. Furthermore, in both studies, the phenomenon of B
cell activation was observed in all strains of mice tested,
irrespective of their genetic resistance to infection and
disease.
Depressed IL-2 secretion and IL-2 receptor expres-
sion by spleen cells in response to Con A stimulation are
two other known consequences of infection with MCMV
(Nicholas et al., 1987; Blackett and Mims, 1988). From our
studies, it appears that the reduced levels of IL-2 can be
ascribed to reduced IL-2 transcription. The capacity of
spleen cells to produce IL-2 in response to Con A, evi-
dent at 3 days after infection, was lost by day 5. This loss
in the ability to produce IL-2 did not correlate with virus
infectivity levels in the spleen, as viral titers were com-
parably high on both day 3 and day 5 after infection (data
not shown). Further, suppression of this response is
FIG. 10. All photomicrographs are of sections of the splenic white pulp stained with hematoxylin and eosin at a magnification of 3200. (A) MHC
class II knockout uninfected mouse spleen with minimal activity in the white pulp; the follicle consists mainly of small lymphocytes, the dark-staining
cells of the mantle zone. There are no germinal centers present in any follicle. (B) Wild-type mouse also uninfected but with a typical small germinal
center within the follicle (lower left) indicating the moderate activity often seen in normal spleen. (C) MHC class II knockout infected with MCMV. The
follicle is about the same size as in the uninfected spleen (A), but there is a loss of mantle zone cells and a continued absence of germinal centers.
(D) Wild-type mouse infected with MCMV with a very large, active germinal center within the follicle occupying the entire central portion of the
photomicrograph.
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known to last for at least 14–18 days p.i. (Nicholas et al.,
1987), whereas virus in the spleen was cleared by day 10
(data not shown). Thus, while active production of virus
per se does not appear to inhibit the capacity of spleen
cells to produce IL-2 in response to Con A stimulation, it
is possible that some viral protein(s) or virus-induced
factor(s), produced as a consequence of virus replication
possibly in a distant organ, e.g., the salivary gland, is
responsible for the suppression of IL-2 production. In this
respect, it is interesting to note that the HIV-1-soluble gp
120 causes a similar suppression of IL-2 production and
IL-2 receptor expression (Oyaizu et al., 1990; Bowen et
al., 1992). The failure of T cells from MCMV-infected mice
to produce IL-2 while maintaining the ability to produce
IFN-g resembles the cytokine profile of anergic Th1-type
cells; however, the ‘‘anergy’’ associated with MCMV is
observed only during the acute phase of infection.
The broad reactivity of antibodies from virally infected
animals was confined to the IgG isotype. By flow cyto-
metric analysis, the most profound changes for surface
expression of the IgG subclasses were the striking in-
creases in IgG2a and IgG2b. Further, by ELIspot assay,
maximal increases were noted in the numbers of IgG2a-
producing cells. Production of this IgG subclass is
strongly stimulated by IFN-g. We successfully demon-
strated, both at the mRNA and at the protein levels, that
this cytokine is produced early in infection. The kinetics
of IFN-g expression following stimulation of spleen cells
with either LPS or Con A suggested that NK cells are
likely to be the predominant source soon after infection
and T cells later on (Figs. 7A and 7B). LPS is known to
induce macrophages to produce IL-12, which, in turn, is
highly efficient at inducing NK cells to produce IFN-g
before virus-specific T cell responses develop (days 3
and 5; Fig. 7B). These results are consistent with earlier
studies that demonstrated a peak in serum levels of
IFN-g at 40 h postinfection and a dependency of this
early response on IL-12 triggering of IFN-g production by
NK cells (Orange and Biron, 1996; Cousens et al., 1997;
Ruzek et al., 1997). Production of IFN-g by NK cells was
found to be facilitated by TNF-a (Orange and Biron,
1996), and early production of both cytokines is sug-
gested to result in macrophage activation as an impor-
tant component of the innate response to virus infection
(Heise and Virgin, 1995). Preferential induction of IFN-g
by Con A at day 7 suggests that T cells may be the
primary source of this cytokine at later time points. This
is consistent with reports that IFN-g secretion by CD41 T
cells is important for the control of virus replication in the
salivary glands (Jonjic et al., 1989; Koszinowski et al.,
1990). Virus seeds this organ later in infection and per-
sists longer than in other organs. Interestingly, and quite
predictably, in mice in which this cytokine was neutral-
ized in vivo (data not shown) or in IFN-g-deficient mice,
the frequency of IgG2a-expressing cells was severely
reduced, but there was a concomitant increase in the
frequency of surface IgG3- and, in particular, IgG1-ex-
pression cells (data not shown). Thus, the absence of
IFN-g did not abolish B cell activation by the criteria used
in these studies but did influence IgG switching prefer-
ence. It is likely that in the absence of IFN-g, enhanced
IL-4 production results that contributes to the shift from
IgG2a to IgG1 expression. In MCMV-infected mice, mRNA
transcripts for IL-4 were severely depressed, and no IL-4
could be detected under the conditions of restimulation
used in our studies. The lack of detection of IL-4 by
ELISA may have been the result of lower levels of sen-
sitivity of this assay. Using the ELIspot assay, IL-4-pro-
ducing cells were detected, but the numbers did not
change significantly over the entire course of infection.
That IL-2 expression (at the protein level) is reduced
during the acute phase of infection with MCMV has been
reported previously (Nicholas et al., 1987; Blackett and
Mims, 1988). The absence of a correlation between IL-2
mRNA (RT-PCR) and protein (ELISA and ELIspot) expres-
sion may be due to posttranscriptional regulation of
cytokine gene expression in vivo.
While mRNA for IL-10 was induced at very high levels
in the spleen following infection with MCMV, no protein
could be detected following restimulation of splenocytes
in vitro.
The rapid induction of mRNA for IL-6, a known B cell
stimulatory factor, was associated with increased spon-
taneous production of the cytokine over the course of
infection with MCMV. Since unregulated and constitutive
production of IL-6 has been associated with polyclonal B
cell activation leading to hypergammaglobulinemia and
autoantibody production in certain tumor-bearing pa-
tients (Hirano et al., 1987) and in individuals infected with
HIV-1 (Breen et al., 1990), we speculated that this factor
may be a major driving force for the polyclonal B cell
activation in MCMV-infected mice. Furthermore, IL-6-
transgenic B lineage cells that develop in SCID or Rag-
2-deficient mice after transplantation give rise to nearly
normal levels of some subclasses of IgG and of IgA (Oka
et al., 1995). Indeed, in IL-6-deficient mice infected with
MCMV, the level of B cell activation was not as dramatic
as in IL-61/1 mice. Furthermore, antibodies reactive with
ovalbumin, myosin, and TNP were reduced by almost
50% in mutant mice compared with virus-infected wild-
type mice. The serum IgG levels in mutant mice were
also lower than those in wild-type mice. Taken together,
these results are consistent with findings that the pro-
duction of autoreactive antibodies in systemic autoim-
munity is due to polyclonal activation and not the specific
stimulation of autoreactive clones (Klinman and Stein-
berg, 1987); however, unlike HIV-1 infections in humans,
IL-6 production in MCMV infection is a transient event.
Another finding that needs to be addressed experi-
mentally is the relevance of the increased frequency of
NK1.11 cells to B cell activation. The kinetics of increased
NK1.1 antigen expression on splenocytes closely paral-
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leled the kinetics of B cell activation. The expression of
the NK cell marker did not correlate with the cytolytic
activity of NK cells (data not shown) in MCMV-infected
mice, because the killing activity declined to nearly back-
ground levels (as in uninfected mice) when NK1.1 expres-
sion was maximal. Indeed, NK cells—known to produce
IFN-g early in infection—have been shown to induce
activated murine B cells to secrete Ig in response to a
T-cell-independent antigen (Snapper et al., 1993).
Virus persistence and the establishment of latency in
the host are classic sequelae of infection with herpesvi-
ruses, which include CMV. Although mechanisms under-
lying the ability of CMV to establish latency are poorly
defined, virus-induced immunosuppression during the
acute phase of infection is believed to be contributory
(Banks and Rouse, 1992). Several other strategies, of
which polyclonal B cell activation could be one, may be
employed by the virus to establish latency.
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